Plain-English translation of NCT07360093 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a two-step treatment approach for chronic hip pain caused by hip arthritis. First, you would receive a pericapsular nerve group (PENG) block—an ultrasound-guided injection that numbs the nerves around your hip joint without affecting your ability to move. If this initial treatment works well for you, you would then receive pulsed radiofrequency (PRF) treatment, which uses gentle energy to modify nerve signals and may provide longer-lasting pain relief.
Many people with chronic hip pain don't get enough relief from medications, physical therapy, and other standard treatments, and surgery isn't safe or appropriate for everyone. Researchers want to learn whether combining this nerve block with radiofrequency treatment can provide better and longer-lasting pain control than the nerve block alone.
You likely qualify if…
You likely don't qualify if…
You would first receive the numbing nerve block injection, guided by ultrasound imaging. If your pain improves by at least 50%, you would then return for the radiofrequency treatment procedure. Both procedures are minimally invasive and typically done in an outpatient clinic setting. The study will track your pain levels and how well you can function in daily activities to see how effective this combined approach is.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Ankara City Hospital Bilkent
Enrollment target
~84 participants
Started
February 2026
Primary completion
February 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ulku Sabuncu MD, Assoc. prof.
Ankara City Hospital Bilkent
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.